- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00556946
Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains (PDT/PDL)
This research study was designed to determine the effect on port wine stains (PWS) of liposomal benzoporphyrin derivative monoacid (BPD-MA) termed verteporfin by intravenous (IV) infusion for photodynamic therapy (PDT) or combined PDT and pulsed dye laser (PDL) therapy (PDT + PDL). The standard treatment for PWS is PDL alone. This lightens some PWS but many lesions are not completely removed.
PDT uses a medication and light together to cause injury to a target. The medication is given and then light is directed at the desired area of treatment to achieve an effect. PDT has been used to treat some skin conditions including pre-cancers and skin cancers. Using PDT or PDT immediately followed by PDL therapy may improve PWS lightening. At this time, both PDT and PDT + PDL therapy for treatment of PWS is investigational. The type and amount of medication and light which may be used to treat PWS is not known, and is likely to be different than those used for other PDT treatments.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Procedures will be performed at the Surgery Laser Clinic at the Beckman Laser Institute at the University of California, Irvine.
At an initial visit, a brief history and physical will be performed.
The history will include: 1) previous treatment to my PWS; 2) current medications; 3) history of light sensitivity; 4) risk of pregnancy and use of birth control in a female of child-bearing age.
The physical will include: 1) measurement and evaluation of PWS; 2) measurement of blood pressure, blood cell count, general chemistries (including liver function tests) and ANA, which might indicate an increased sensitivity to light.
On the day of treatment, the same brief physical and history will be repeated. A urine pregnancy test will be performed on females of child-bearing age.
Four circular test sites of PWS will be selected. One test site will receive no treatment. The second test sites will be treated with the pulsed dye laser at standard setting and protective eyeglasses to shield the eyes during the laser treatment.
For two additional test spots, the photodynamic therapy (PDT) verteporfin will be administered intravenously over a 10-minute period. After receiving the verteporfin, the skin and eyes will be sensitive to light for the next 5 days. The light sensitive protection precautions will be instructed.
Optical Doppler Tomography unit (ODT) measurements, similar to shining a flash light to PWS and measuring the light response, which provide information about how blood is flowing through the PWS.
Photographs and light measurements will be taken during follow-up visits on day 1, day 3, and 1, 2, 4, 8 and 12 weeks after the study treatment. At these visits blood may also be drawn to check for blood substances that promote blood vessel formation.
At the end of the study, blood tests will be drawn to assess cell count and general chemistries.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Irvine, California, United States, 02612
- Beckman Laser Medical Clinic,University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult 18 years and older
- Have a PWS on an area other than the face
- A negative pregnancy test and non pregnant or nursing
Exclusion Criteria:
- Under 18 years of age
- Have an allergy to verteporfin, porfimer sodium or other porphyrins
- Have a history of porphyria (a disease that can cause sensitivity to light)
- Have had treatment to the PWS test sites in the last 8 weeks
- Have an active uncontrolled infection or other significant disease
- Currently using medications that cause sensitivity to light such as tetracyclines, sulfonamides, phenothiazines, sulfonylurea hypoglycemic agents, thiazide diuretics and griseofulvin
- Currently using medications that increase bleeding, including aspirin, coumadin or non-steroidal anti-inflammatory drugs
- Have very dark skin which is sensitive to laser treatment
- Have a positive ANA (lab tests which indicates sensitivity to light)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Combined Photodynamic & Pulsed Dye Laser Treatment
Treatment of Port Wine Stains
|
Treatment of Port Wine Stains using Combined Photodynamic and Pulsed Dye Laser
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Blanching of Port Wine Stain Birthmark
Time Frame: 12 weeks
|
12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kristen Kelly, MD, Beckman Laser Institute University of California Irvine
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20033286
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Port Wine Stains
-
Centre Hospitalier Universitaire de NiceCompletedPort-wine StainsFrance
-
University of Lausanne HospitalsUnknownPort-wine Stains (PWS)
-
Henry VasconezGraceway Pharmaceuticals, LLCTerminated
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedPort Wine StainsUnited States
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...CompletedPort-wine StainChina
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedPort-wine StainUnited States
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedPORT WINE STAINUnited States
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...Completed
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...Not yet recruitingPort-Wine Stain | Nevus Flammeus | Port-wine Birthmark
Clinical Trials on Combined Photodynamic & Pulsed Dye Laser Treatment
-
University of California, IrvineBeckman Laser Institute University of California Irvine; Candela CorporationCompleted
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedPort Wine StainsUnited States
-
University Hospital, GhentCompleted
-
Taipei Medical University WanFang HospitalTerminated
-
Northwestern UniversityEnrolling by invitation
-
Thomas Jefferson UniversityCompleted
-
University Hospital, CaenCompleted
-
Syneron MedicalCompleted
-
Mahidol UniversityDermatological Society of ThailandCompletedHypertrophic Scars | KeloidsThailand
-
University of ManitobaRecruiting